Analysts noted that while TEPEZZA OBI showed stronger efficacy data, Viridian’s elegrobart offers greater convenience with ...
Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and ...
In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after ...
Speed to market wont guarantee success in todays launch environment. Anticipating what prescribers, patients and payers will ...
Hidden in the quiet corners of Harare’s affluent suburbs, a growing trend is emerging — one that experts warn could pose serious risks to public health.They call it aesthetic cosmetology.By definition ...
Morning Overview on MSN
Nanoparticle therapy targets lung tumors and cancer-related muscle loss
A team at Oregon State University has engineered lipid nanoparticles that deliver messenger RNA to lung tumors while ...
Hydration Room, a Southern California-based chain of IV and injection therapy clinics, opened a new location in Los Gatos as ...
Deaths in Mexico put spotlight on vitamin IV industry growing in Arizona. What’s really in your vitamin drip? Experts urge ...
Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.
Evidence gaps include limited topline safety granularity, unknown long-term follow-up and retreatment rates, and lack of ...
The crew of Artemis II flew farther from Earth than any human in history, saw parts of the moon never seen before and spoke ...
On-body injector delivery of subcutaneous teprotumumab achieves clinically meaningful proptosis reduction in phase 3 thyroid eye disease study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results